These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 3919944

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Interactions between calcium antagonists, calcium fluxes and anthracycline transport.
    Kessel D, Wilberding C.
    Cancer Lett; 1984 Nov; 25(1):97-101. PubMed ID: 6097354
    [Abstract] [Full Text] [Related]

  • 5. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
    Tsuruo T.
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
    [Abstract] [Full Text] [Related]

  • 6. Sensitivity to anthracyclines in P388/dx leukaemia cells.
    Bossa R, Dasdia T, Galatulas I, Zunino F.
    Anticancer Res; 1986 Mar; 6(5):1037-9. PubMed ID: 3099628
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mode of action of calcium antagonists which alter anthracycline resistance.
    Kessel D, Wilberding C.
    Biochem Pharmacol; 1984 Apr 01; 33(7):1157-60. PubMed ID: 6585204
    [No Abstract] [Full Text] [Related]

  • 11. Reversal of multidrug resistance by non-antitumor anthracycline analogs.
    Inaba M, Nagashima K, Sakurai Y, Fukui M, Yanagi Y.
    Gan; 1984 Dec 01; 75(12):1049-52. PubMed ID: 6597118
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Enhancement of doxorubicin and vinblastine sensitivity in anthracycline-resistant P388 cells.
    Ramu A, Shan TC, Glaubiger D.
    Cancer Treat Rep; 1983 Oct 01; 67(10):895-9. PubMed ID: 6354437
    [Abstract] [Full Text] [Related]

  • 15. Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline.
    Ramu N, Ramu A, Cole DE, Balis FM, Poplack DG, Pollard HB.
    Isr J Med Sci; 1988 Oct 01; 24(9-10):477-82. PubMed ID: 2974448
    [Abstract] [Full Text] [Related]

  • 16. Cellular accumulation and disposition of aclacinomycin A.
    Egorin MJ, Clawson RE, Ross LA, Schlossberger NM, Bachur NR.
    Cancer Res; 1979 Nov 01; 39(11):4396-400. PubMed ID: 498071
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Exploring multidrug resistance using rhodamine 123.
    Kessel D.
    Cancer Commun; 1989 Nov 01; 1(3):145-9. PubMed ID: 2639727
    [Abstract] [Full Text] [Related]

  • 20. Effect of Calphostin C (PKC inhibitor) on daunorubicin resistance in P388/ADR and HL60/AR cells: reversal of drug resistance possibly via P-glycoprotein.
    Gupta S, Patel K, Singh H, Gollapudi S.
    Cancer Lett; 1994 Jan 30; 76(2-3):139-45. PubMed ID: 7511983
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.